Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Teriparatide Atc Code According To Who H05Aa02

Deadline: 31 Jan 2028

Germany

Ref. No.: 21532995

EMD:Ref Document

Bid Value: Ref Document

609 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Abiraterone Exclusively 500 Mg 90 Pieces Atc L02Bx03 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21499594

EMD:Ref Document

Bid Value: Ref Document

491 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Aflibercept Except 114 3 Mg Ml Atc S01La05 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21499070

EMD:Ref Document

Bid Value: Ref Document

491 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21494069

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Leuprorelin Atc L02Ae02 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21493659

EMD:Ref Document

Bid Value: Ref Document

491 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Doravirine Atc J05Ag06 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21493157

EMD:Ref Document

Bid Value: Ref Document

491 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Doravirine Lamivudine Tenofovir Disoproxil Fumarate Atc J05Ar24 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21492432

EMD:Ref Document

Bid Value: Ref Document

491 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21489590

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab Exclusively In The Dafo Ifk F D Time 12 01 25 11 30 26 Plus Extension Option 1X12 Months

Deadline: 05 Oct 2027

Germany

Ref. No.: 21487538

EMD:Ref Document

Bid Value: Ref Document

491 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Sumatriptan Excluding Film Coated Tablets And Tablets Atc N02Cc01 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21487226

EMD:Ref Document

Bid Value: Ref Document

491 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tocilizumab Exclusively Pre Filled Syringe And Pre Filled Pen Atc L04Ac07 For The Period December 1St 2025 November 30T

Deadline: 05 Oct 2027

Germany

Ref. No.: 21485597

EMD:Ref Document

Bid Value: Ref Document

491 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Haloperidol Exclusively Injection Solution Atc N05Ad01 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21484867

EMD:Ref Document

Bid Value: Ref Document

491 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tocilizumab Exclusively Infusion Solution Concentrate Atc L04Ac07 For The Period December 1St 2025 November 30Th 2027

Deadline: 05 Oct 2027

Germany

Ref. No.: 21484801

EMD:Ref Document

Bid Value: Ref Document

491 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21475392

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21469181

EMD:Ref Document

Bid Value: Ref Document

213 Days Left

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

FREE Trial plan for all new users!